Want in on AI Superstar Anthropic Before Its IPO? These 4 Companies Are Some of Its Earliest Investors.

Anthropic is reported as a potential pre-year-end IPO candidate at a $1 trillion valuation, highlighting strong investor appetite for AI infrastructure and frontier model developers. The article notes that investors can gain indirect exposure through early Anthropic backers Alphabet, Salesforce, Zoom, and Amazon, with Alphabet's stake estimated at roughly 14% after committing up to $40 billion more. The piece is largely informational and speculative, but it underscores the growing value of private AI assets and the potential for a major 2026-style listing event.

Analysis

The market is starting to treat frontier AI exposure as a private-markets carry trade before it is an operating-equity trade. If Anthropic prices anywhere near the implied trillion-dollar mark, the listed “seed holders” won’t just mark up on paper; they could use the gains to fund bigger cloud, sales automation, and collaboration spending, which indirectly benefits the hyperscalers and enterprise software vendors already tied into the model stack. The bigger second-order effect is that a public Anthropic would crystallize a valuation benchmark for the rest of the AI application layer, making today’s premium multiples on public AI names look either justified or embarrassingly rich within one quarter.

The clearest winner is AMZN, but not because of the equity stake alone. The strategic value is that Anthropic deepens AWS workload lock-in at exactly the moment inference economics start to matter more than training hype; if Anthropic scales, compute consumption becomes more durable and less fungible than generic cloud usage. GOOGL also benefits, but the real signal is defensive: Google’s ownership helps keep a top-tier model vendor from becoming a pure Microsoft/OpenAI anchor, which preserves optionality in enterprise AI distribution and may slow share gains by rivals in cloud and productivity.

CRM and ZM are more levered to sentiment than cash flow. A visible Anthropic IPO can re-rate enterprise software names that can credibly claim “AI workflow” exposure, but it also raises the bar for product proof: if standalone model companies can command frontier multiples, software vendors without measurable AI monetization may see investors demand faster payback on AI spend. NVDA’s direct read-through is muted near term, but any public valuation boom in model companies can extend the capex cycle by 6-12 months as each player races to justify scarcity premiums.

The contrarian risk is that the IPO narrative may peak before monetization does. If open-source and commoditized reasoning models keep improving, the market could start discounting “model ownership” and rewarding distribution + data instead, which would compress the multiple of any public Anthropic quickly. The other tail risk is concentration: if the IPO is priced as a winner-take-all asset, secondary holders may rush to monetize, creating a short, sharp post-deal overhang even if the long-term story remains intact.

Key Decisions for Investors

• Go overweight AMZN vs. QQQ over the next 3-6 months; the stock has the cleanest operating leverage to AI infra demand plus the highest optionality if Anthropic becomes a public benchmark.
• Pair trade: long GOOGL / short CRM for 1-3 months; GOOGL has direct model upside and cloud defensiveness, while CRM is more exposed to narrative-driven multiple expansion without equivalent balance-sheet leverage.
• Buy NVDA December upside call spreads only on weakness, not strength; use the IPO window as a sentiment catalyst, but cap premium because the stock already discounts a long AI capex cycle.
• Avoid chasing ZM into the event; if Anthropic rerates the AI software basket, ZM may pop on sympathy but lacks a second-order monetization path, making it a sell-into-strength candidate.
• If a filing/reported financing round confirms the IPO timeline, add a small basket long of GOOGL/AMZN and hedge with short NDX futures for 2-4 weeks; the trade captures AI-specific dispersion while limiting market beta if the IPO hype fades.